Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7136
Rank
HK$4.28 B
Marketcap
HK$214.27
Share price
-1.35%
Change (1 day)
-17.69%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement